Difficulty: Medium
Average Score: 70%
Practice
Currently used oral hypoglycemic thiazolidinediones include the following, EXCEPT:
Correct answer
C
Rationale
In this question on currently used oral hypoglycemic thiazolidinediones, the correct answer is C) Troglitazone (Rezulin) because troglitazone was withdrawn from the market due to severe hepatotoxicity concerns. Pioglitazone (Actos) and Rosiglitazone (Avandia) are still used in clinical practice.
Pioglitazone and Rosiglitazone are both examples of thiazolidinediones that are currently used to treat type 2 diabetes by improving insulin sensitivity. Pioglitazone is known to be associated with weight gain and edema, while Rosiglitazone has been linked to an increased risk of cardiovascular events.
Troglitazone, on the other hand, was the first thiazolidinedione available in the United States but was withdrawn from the market because of its potential to cause severe liver damage. This educational context highlights the importance of understanding the pharmacological properties and potential adverse effects of medications used in the treatment of diabetes across the lifespan.
It is crucial for healthcare providers to stay updated on the current pharmacological options available for managing diabetes to ensure safe and effective treatment. Understanding the specific characteristics of each medication, including their benefits and risks, is essential for optimizing patient outcomes and promoting medication safety.
Pioglitazone and Rosiglitazone are both examples of thiazolidinediones that are currently used to treat type 2 diabetes by improving insulin sensitivity. Pioglitazone is known to be associated with weight gain and edema, while Rosiglitazone has been linked to an increased risk of cardiovascular events.
Troglitazone, on the other hand, was the first thiazolidinedione available in the United States but was withdrawn from the market because of its potential to cause severe liver damage. This educational context highlights the importance of understanding the pharmacological properties and potential adverse effects of medications used in the treatment of diabetes across the lifespan.
It is crucial for healthcare providers to stay updated on the current pharmacological options available for managing diabetes to ensure safe and effective treatment. Understanding the specific characteristics of each medication, including their benefits and risks, is essential for optimizing patient outcomes and promoting medication safety.